• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies.从糖耐量受损进展为非胰岛素依赖型糖尿病的预测因素:六项前瞻性研究的分析
Diabetes. 1997 Apr;46(4):701-10. doi: 10.2337/diab.46.4.701.
2
Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.南非印度人中的短暂性糖耐量受损不会增加进展为非胰岛素依赖型糖尿病的风险。
Diabetes Care. 1997 Jul;20(7):1101-7. doi: 10.2337/diacare.20.7.1101.
3
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.饮食和运动对糖耐量受损人群预防非胰岛素依赖型糖尿病的作用。大庆糖耐量受损和糖尿病研究。
Diabetes Care. 1997 Apr;20(4):537-44. doi: 10.2337/diacare.20.4.537.
4
Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians.腹部肥胖和缺乏身体活动作为印度裔、克里奥尔裔和华裔毛里求斯人患非胰岛素依赖型糖尿病及糖耐量受损的风险因素。
Diabetes Care. 1991 Apr;14(4):271-82. doi: 10.2337/diacare.14.4.271.
5
[Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].[迈向2型糖尿病一级预防的步骤。各种流行病学考量]
Invest Clin. 1997 Mar;38(1):39-52.
6
Prevalence of non-insulin-dependent diabetes mellitus and impaired glucose tolerance in two Algonquin communities in Quebec.魁北克两个阿尔冈昆社区中非胰岛素依赖型糖尿病和糖耐量受损的患病率。
CMAJ. 1993 Jan 1;148(1):41-7.
7
Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.纤溶酶原激活物抑制剂(PAI-1)活性在患有非胰岛素依赖型(2型)糖尿病的亚洲和白种人受试者中升高,但在糖耐量受损(IGT)的受试者或非糖尿病亚洲人中并未升高。
Diabet Med. 1996 Jan;13(1):59-64. doi: 10.1002/(SICI)1096-9136(199601)13:1<59::AID-DIA2>3.0.CO;2-Z.
8
The prevalence of NIDDM and associated risk factors in native Canadians.加拿大原住民中2型糖尿病(NIDDM)的患病率及相关风险因素。
Diabetes Care. 1997 Feb;20(2):185-7. doi: 10.2337/diacare.20.2.185.
9
Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes.老年人群中糖尿病和糖耐量受损的患病率及其与肥胖和糖尿病家族史的关联。
Diabetes Care. 1990 Nov;13(11):1099-105. doi: 10.2337/diacare.13.11.1099.
10
Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.南印度糖尿病前期受试者的遗传研究。高胰岛素血症和β细胞功能障碍的重要性。
Diabetes Care. 1998 Jan;21(1):76-9. doi: 10.2337/diacare.21.1.76.

引用本文的文献

1
The association between indoor biofuel use for cooking and glucose metabolism in adults: A cross-sectional study in Tanzania.成人室内使用生物燃料烹饪与葡萄糖代谢之间的关联:坦桑尼亚的一项横断面研究。
PLOS Glob Public Health. 2025 May 14;5(5):e0003816. doi: 10.1371/journal.pgph.0003816. eCollection 2025.
2
Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity.多囊卵巢综合征:诊断标准、表型、种族与族裔
Reprod Med Biol. 2025 Jan 22;24(1):e12630. doi: 10.1002/rmb2.12630. eCollection 2025 Jan-Dec.
3
The sleep for health study: A randomized clinical trial of the impact of insomnia treatment on glycemia in people with prediabetes.睡眠对健康的影响研究:一项关于失眠治疗对糖尿病前期患者血糖影响的随机临床试验。
Contemp Clin Trials. 2025 Feb;149:107796. doi: 10.1016/j.cct.2024.107796. Epub 2024 Dec 25.
4
Identifying critical age and gender-based metabolomic shifts in a Japanese population of the Tohoku Medical Megabank cohort.在日本东北地区医疗巨型数据库队列人群中,确定关键的年龄和性别代谢组学变化。
Sci Rep. 2024 Jul 8;14(1):15681. doi: 10.1038/s41598-024-66180-0.
5
Association between visceral adiposity index and risk of diabetes and prediabetes: Results from the NHANES (1999-2018).内脏脂肪指数与糖尿病及糖尿病前期风险之间的关联:美国国家健康与营养检查调查(1999 - 2018年)结果
PLoS One. 2024 Apr 25;19(4):e0299285. doi: 10.1371/journal.pone.0299285. eCollection 2024.
6
Effects of a dietary intervention on cardiometabolic risk and food consumption in a workplace.饮食干预对工作场所心脏代谢风险和食物消费的影响。
PLoS One. 2024 Apr 24;19(4):e0301826. doi: 10.1371/journal.pone.0301826. eCollection 2024.
7
Indications for the Postpartum Oral Glucose Tolerance Test.产后口服葡萄糖耐量试验的适应证。
Dtsch Arztebl Int. 2024 Apr 19;121(8):251-257. doi: 10.3238/arztebl.m2024.0034.
8
Prevalence of prediabetes by the fasting plasma glucose and HbA1c screening criteria among the children and adolescents of Shenzhen, China.中国深圳儿童及青少年中采用空腹血糖和糖化血红蛋白筛查标准的糖尿病前期患病率
Front Endocrinol (Lausanne). 2024 Jan 19;15:1301921. doi: 10.3389/fendo.2024.1301921. eCollection 2024.
9
Treat Obesity to Treat Type 2 Diabetes Mellitus.治疗肥胖以治疗2型糖尿病。
Diabetes Ther. 2024 Mar;15(3):611-622. doi: 10.1007/s13300-024-01536-3. Epub 2024 Feb 4.
10
Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial.阿卡波糖心血管评估试验中冠心病合并糖耐量受损患者的医疗资源和费用比较。
J Diabetes. 2024 Feb;16(2):e13473. doi: 10.1111/1753-0407.13473. Epub 2023 Nov 1.

本文引用的文献

1
Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study.空腹胰岛素原水平和负荷后2小时血糖水平可预测糖耐量受损患者向非胰岛素依赖型糖尿病的转变:霍恩研究
Diabetologia. 1996 Jan;39(1):113-8. doi: 10.1007/BF00400421.
2
Surveillance for diabetes mellitus--United States, 1980-1989.美国1980 - 1989年糖尿病监测
MMWR CDC Surveill Summ. 1993 Jun 4;42(2):1-20.
3
High risk of progression to NIDDM in South-African Indians with impaired glucose tolerance.糖耐量受损的南非印度人进展为非胰岛素依赖型糖尿病的风险很高。
Diabetes. 1993 Apr;42(4):556-63. doi: 10.2337/diab.42.4.556.
4
Prevalence of cardiovascular and renal complications in older adults with normal or impaired glucose tolerance or NIDDM. A population-based study.糖耐量正常、糖耐量受损或非胰岛素依赖型糖尿病的老年人心血管和肾脏并发症的患病率。一项基于人群的研究。
Diabetes Care. 1993 Jul;16(7):1022-5. doi: 10.2337/diacare.16.7.1022.
5
Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. The San Luis Valley Diabetes Study.膳食脂肪可预测糖耐量受损向非胰岛素依赖型糖尿病的转变。圣路易斯谷糖尿病研究。
Diabetes Care. 1994 Jan;17(1):50-6. doi: 10.2337/diacare.17.1.50.
6
Proinsulin as a marker for the development of NIDDM in Japanese-American men.胰岛素原作为日裔美国男性非胰岛素依赖型糖尿病发病的一个标志物。
Diabetes. 1995 Feb;44(2):173-9. doi: 10.2337/diab.44.2.173.
7
Preventing non-insulin-dependent diabetes.预防非胰岛素依赖型糖尿病。
Diabetes. 1995 May;44(5):483-8. doi: 10.2337/diab.44.5.483.
8
Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans.胰岛素分泌减少和胰岛素抵抗增加与墨西哥裔美国人患非胰岛素依赖型糖尿病的7年风险独立相关。
Diabetes. 1995 Dec;44(12):1386-91. doi: 10.2337/diab.44.12.1386.
9
Comparison of body size measurements as predictors of NIDDM in Pima Indians.
Diabetes Care. 1995 Apr;18(4):435-9. doi: 10.2337/diacare.18.4.435.
10
Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation.糖耐量受损受试者的十年随访:甲苯磺丁脲与饮食调节预防糖尿病
Diabetes. 1980 Jan;29(1):41-9. doi: 10.2337/diab.29.1.41.

从糖耐量受损进展为非胰岛素依赖型糖尿病的预测因素:六项前瞻性研究的分析

Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies.

作者信息

Edelstein S L, Knowler W C, Bain R P, Andres R, Barrett-Connor E L, Dowse G K, Haffner S M, Pettitt D J, Sorkin J D, Muller D C, Collins V R, Hamman R F

机构信息

George Washington University Biostatistics Center, Rockville, Maryland 20852, USA.

出版信息

Diabetes. 1997 Apr;46(4):701-10. doi: 10.2337/diab.46.4.701.

DOI:10.2337/diab.46.4.701
PMID:9075814
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2517225/
Abstract

Risk factors associated with the progression from impaired glucose tolerance (IGT) to NIDDM were examined in data from six prospective studies. IGT and NIDDM were defined in all studies by World Health Organization (WHO) criteria, and baseline risk factors were measured at the time of first recognition of IGT. The studies varied in size from 177 to 693 participants with IGT, and included men and women followed from 2 to 27 years after the recognition of IGT. Across the six studies, the incidence rate of NIDDM was 57.2/1,000 person-years and ranged from 35.8/1,000 to 87.3/1,000 person-years. Although baseline measures of fasting and 2-h postchallenge glucose levels were both positively associated with NIDDM incidence, incidence rates were sharply higher for those in the top quartile of fasting plasma glucose levels, but increased linearly with increasing 2-h postchallenge glucose quartiles. Incidence rates were higher among the Hispanic, Mexican-American, Pima, and Nauruan populations than among Caucasians. The effect of baseline age on NIDDM incidence rates differed among the studies; the rates did not increase or rose only slightly with increasing baseline age in three of the studies and formed an inverted U in three studies. In all studies, estimates of obesity (including BMI, waist-to-hip ratio, and waist circumference) were positively associated with NIDDM incidence. BMI was associated with NIDDM incidence independently of fasting and 2-h post challenge glucose levels in the combined analysis of all six studies and in three cohorts separately, but not in the three studies with the highest NIDDM incidence rates. Sex and family history of diabetes were generally not related to NIDDM progression. This analysis indicates that persons with IGT are at high risk and that further refinement of risk can be made by other simple measurements. The ability to identify persons at high risk of NIDDM should facilitate clinical trials in diabetes prevention.

摘要

在六项前瞻性研究的数据中,对与糖耐量受损(IGT)进展为非胰岛素依赖型糖尿病(NIDDM)相关的危险因素进行了研究。在所有研究中,IGT和NIDDM均按照世界卫生组织(WHO)标准定义,基线危险因素在首次确诊IGT时进行测量。这些研究的规模从177名至693名患有IGT的参与者不等,包括在确诊IGT后随访2至27年的男性和女性。在这六项研究中,NIDDM的发病率为57.2/1000人年,范围从35.8/1000至87.3/1000人年。尽管空腹和餐后2小时血糖水平的基线测量值均与NIDDM发病率呈正相关,但空腹血糖水平处于最高四分位数的人群发病率显著更高,而餐后2小时血糖四分位数升高时发病率呈线性增加。西班牙裔、墨西哥裔美国人、皮马人和瑙鲁人群中的发病率高于白种人。基线年龄对NIDDM发病率的影响在各项研究中有所不同;在三项研究中,发病率并未随基线年龄增加而升高或仅略有上升,而在三项研究中呈倒U形。在所有研究中,肥胖估计值(包括体重指数、腰臀比和腰围)与NIDDM发病率呈正相关。在所有六项研究的综合分析以及三项队列研究中,体重指数与NIDDM发病率相关,且独立于空腹和餐后2小时血糖水平,但在NIDDM发病率最高的三项研究中并非如此。性别和糖尿病家族史通常与NIDDM进展无关。该分析表明,IGT患者处于高风险,并且通过其他简单测量可以进一步细化风险评估。识别NIDDM高风险人群的能力应有助于糖尿病预防的临床试验。